Pharmaceutical IP and competition law in Poland: overview | Practical Law
A Q&A guide to pharmaceutical IP and competition law in Poland.
Enter to open, tab to navigate, enter to select
US Home
Global Home
NEW
Sign in
Sign in
All content
Search:
Search Westlaw
Search Tips
Advanced
Pharmaceutical IP and competition law in Poland: overview
Practical Law Country Q&A 3-633-4005
(Approx. 17 pages)
Pharmaceutical IP and competition law in Poland: overview
by Dr Aleksandra Auleytner and Tomasz Kaczyński,
Domański Zakrzewski Palinka
Related Content
Law stated as at 01 Dec 2020
•
Poland
A Q&A guide to pharmaceutical IP and competition law in Poland.
The Q&A gives a high level overview of key issues including patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports.
For information on pharmaceutical pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability, visit
Medicinal product regulation and product liability in Poland: overview
.